DuPont de Nemours, Inc. — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 42/100
What the filing says
DuPont reported Q2 2026 net sales of $1.819B (up 4% YoY organic), GAAP continuing operations income of $191M, adjusted EPS of $1.88 (vs. prior guidance), and operating EBITDA of $448M. The company raised full-year 2026 guidance: operating EBITDA to ~$1.76B midpoint, adjusted EPS to $7.24/share, and organic sales growth to slightly above 4%. DuPont announced a $250M share repurchase for Q3 2026 and a GICS reclassification from Materials to Industrials effective July 31, 2026. Key performance drivers: Healthcare & Water Technologies organic growth of 4%, Diversified Industrials of 3%, transaction-adjusted free cash flow conversion of 127%, and $326M transaction-adjusted FCF in Q2.
Why this rating
Strong Q2 beat and FY guidance raise are encouraging, but represent incremental improvement at a $12B company. Transaction-adjusted FCF and $250M buyback provide modest capital support. Reclassification to Industrials is administrative. No transformational deal or structural change.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.